Back to News
Market Impact: 0.3
Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies
Source: 247wallst.com
Healthcare & BiotechMarket Technicals & Flows
Vaccine and biotechnology stocks are leading a sharp sector rally, with Novavax the group's biggest gainer. Novavax shares recently traded at $12.77, up 16%; the article gives no specific catalyst.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
NVAX0.60
More News
- Verizon stock heads for worst day since 2002 as SpaceX U.S. network plans whack telcos
- French yields are near levels not seen since 2002. Why that could give U.S. Treasurys a boost
- What's behind the recovery rally in tech stocks — plus, Elon Musk's very good week
- SpaceX’s Wireless Threat Rises With Spectrum Deal
- Pilot killed in attacks by Iran-backed Houthis on Riyadh airport; Saudi-led coalition vows 'firm' response
- OpenAI's revenue scare, Delta earnings, what investors think of a Starbucks-Chipotle deal and more in Morning Squawk
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Stop Treating AI Like a Chatbot: What Are Agents, SubAgents, MCP, and Skills, and How Do They Actually Work?
- Earnings-Triggered Research Automations: A Control Guide